Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Cyabra Signs Agreement Valued at More Than $500,000 to Provide AI-Powered Narrative Intelligence and Disinformation Security Solutions to Leading International Research Institute
Jun 8, 2026
Maya Rios
Press Releases

Cyabra Signs Agreement Valued at More Than $500,000 to Provide AI-Powered Narrative Intelligence and Disinformation Security Solutions to Leading International Research Institute

Cyabra, Inc., a Nasdaq-listed AI-powered disinformation intelligence platform, announced a new agreement exceeding $500,000 to provide advanced narrative intelligence and authenticity solutions to a major international research institute focused on exposing global hate speech. This partnership expands Cyabra's role in combating coordinated online d…

CYAB
Ormat Technologies Accelerates Enhanced Geothermal System (EGS) Deployments and Introduces Ormega100 Unit to Commercialize and Scale the Largest Binary Unit in the Industry
Jun 8, 2026
Marcus Reed
Press Releases

Ormat Technologies Accelerates Enhanced Geothermal System (EGS) Deployments and Introduces Ormega100 Unit to Commercialize and Scale the Largest Binary Unit in the Industry

Ormat Technologies announced the Ormega100, the industry's largest binary surface power generation unit designed to deliver 100 MW output for enhanced geothermal system (EGS) deployments. Backed by 60 years of geothermal expertise, Ormat aims to rapidly commercialize next-gen geothermal solutions combining subsurface and surface technologies to mee…

ORA
Inter Opens U.S. Branch in Miami
Jun 8, 2026
Avery Klein
Press Releases

Inter Opens U.S. Branch in Miami

Inter, a global fintech and digital banking platform with over 44 million customers, announced the opening of its U.S. branch in Miami, Florida. Authorized by U.S. regulatory bodies, the branch strengthens Inter's ability to serve clients with U.S.-related financial needs, supports cross-border financial activities, optimizes funding, and furthers …

INTR
Marex appoints Georges Assi to the Group Board
Jun 8, 2026
Ajmal Hussain
Press Releases

Marex appoints Georges Assi to the Group Board

Marex Group plc, a global financial services platform, announced the appointment of Georges Assi to its Group Board, where he will serve on the Risk Committee. Assi brings extensive experience from investment banking and fintech entrepreneurship, including leadership roles at Sigma Lending and Naviter Capital. Marex expects his expertise in technol…

MRX
Nasdaq Halts JIADE LIMITED
Jun 8, 2026
Caleb Monroe
Press Releases

Nasdaq Halts JIADE LIMITED

Nasdaq has halted trading in JIADE LIMITED (ticker: JDZG) as of June 4, 2026, due to the company not providing requested additional information. Trading will remain suspended until Nasdaq's inquiries are fully addressed. The last closing price before the halt was $50 per Class A ordinary share.

JDZG
Broadcom Expands Its Investment in Spring and Java Ecosystem Security to Prepare Customers for AI-Enabled Threats
Jun 8, 2026
Derek Hwang
Press Releases

Broadcom Expands Its Investment in Spring and Java Ecosystem Security to Prepare Customers for AI-Enabled Threats

Broadcom Inc. announced major investments to enhance security in the widely used Spring and Java ecosystems, including the largest set of Spring security updates in its history and AI-assisted vulnerability detection and remediation. These efforts aim to protect customers against the rise of AI-enabled threats by providing day-zero access to valida…

AVGO
QED to invest in FEMSA’s lending venture
Jun 8, 2026
Avery Klein
Press Releases

QED to invest in FEMSA’s lending venture

FEMSA has entered into a strategic equity investment agreement with QED Investors, a fintech-focused venture capital firm, to support and accelerate the development of its lending business unit. This partnership leverages FEMSA's extensive customer network and data with QED's expertise in fintech, lending, risk management, and product development, …

FMX
V Gallant’s Fintech Partner Credilab Secures Full Online Lending Approval in Malaysia, Advancing Revenue-Share AI Lending Platform
Jun 8, 2026
Nina Shah
Press Releases

V Gallant’s Fintech Partner Credilab Secures Full Online Lending Approval in Malaysia, Advancing Revenue-Share AI Lending Platform

VCI Global Limited's subsidiary V Gallant announces that its fintech partner Credilab has received regulatory approval to operate as a fully online lending platform in Malaysia. This milestone allows Credilab to scale its digital lending operations using V Gallant's AI infrastructure, supporting automated workflows and intelligent lending processes…

VCIG
Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today
Jun 8, 2026
Sofia Navarro
Press Releases

Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today

Fort Technology Inc., a majority-owned subsidiary of Nexera Technologies Ltd, has commenced trading on the Nasdaq Capital Market under the ticker symbol FRTT. Nexera holds approximately 70.94% of Fort's shares following this listing, which enhances Fort's financial visibility and access to U.S. capital markets. Fort continues trading on the TSX Ven…

FRTT
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Jun 8, 2026
Leila Farooq
Press Releases

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

AIM ImmunoTech reports encouraging mid-year progress in their ongoing Phase 2 DURIPANC study evaluating Ampligen in combination with AstraZeneca’s Imfinzi for metastatic pancreatic cancer patients. Enrollment has completed and the trial remains on track for December 2026 endpoint evaluation. Prior data indicate Ampligen’s potential to significantly…

AIM
Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security
Jun 8, 2026
Nina Shah
Press Releases

Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security

Foresight Autonomous Holdings Ltd. has secured a $17.5 million strategic equity investment from VisionWave Holdings, intended to integrate advanced AI with Foresight's 3D perception systems to create enhanced real-time perception solutions for defense and security applications. VisionWave will acquire a controlling 52% stake in Foresight through a …

FRSX
Consolidated Water Appoints Water Industry Veteran Sachin Chawla as Senior Vice President, Strategy and Growth
Jun 8, 2026
Avery Klein
Press Releases

Consolidated Water Appoints Water Industry Veteran Sachin Chawla as Senior Vice President, Strategy and Growth

Consolidated Water Co. Ltd. has named Sachin Chawla as Senior Vice President, Strategy and Growth, to lead business development, sales, and marketing while supporting M&A and company expansion initiatives. The company reported strong operational performance in 2025 and early 2026, with new U.S. contract awards and desalination projects underway, po…

CWCO
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
Jun 8, 2026
Derek Hwang
Press Releases

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Conexeu Sciences Inc. reports significant progress in scaling up manufacturing and establishing standardized formulation processes with its contract manufacturer for its lead CXU™ wound care device. The company is preparing for a planned 510(k) premarket notification submission to the FDA in Q1 2027, transitioning the product from research developm…

CNXU
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation
Jun 8, 2026
Nina Shah
Press Releases

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

The U.S. Court of Appeals for the Federal Circuit upheld a previous ruling that CorMedix Therapeutics' patents for MINOCIN® for Injection are valid and infringed by Nexus Pharmaceuticals' generic product. This affirms the intellectual property protection of the antibiotic, maintaining CorMedix’s exclusive rights to market their innovative intraveno…

CRMD